Barclays PLC Embecta Corp. Transaction History

Barclays PLC

$353 Billion
Q1 2025

A detailed history of Barclays PLC transactions in Embecta Corp. stock. As of the latest transaction made, Barclays PLC holds 131,888 shares of EMBC stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

131,888

Previous 146,983 10.27%

Holding current value

$1.82 Million

Previous $3.04 Million 44.61%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$12.28 - $20.93 $185,366 - $315,938	-15,095 Reduced 10.27%	131,888 $1.68 Million
Q4 2024 Feb 13, 2025	BUY	$12.51 - $20.83 $613,653 - $1.02 Million	49,053 Added 50.09%	146,983 $3.04 Million
Q3 2024 Nov 15, 2024	BUY	$11.46 - $16.56 $326,873 - $472,340	28,523 Added 41.1%	97,930 $1.38 Million
Q2 2024 Aug 14, 2024	SELL	$10.13 - $14.6 $374,739 - $540,097	-36,993 Reduced 34.77%	69,407 $867,000
Q1 2024 May 15, 2024	SELL	$12.35 - $19.33 $1.65 Million - $2.59 Million	-133,918 Reduced 55.73%	106,400 $1.41 Million
Q4 2023 Feb 15, 2024	SELL	$12.87 - $19.09 $3.78 Million - $5.6 Million	-293,587 Reduced 54.99%	240,318 $4.55 Million
Q3 2023 Nov 07, 2023	BUY	$15.0 - $22.17 $7.22 Million - $10.7 Million	481,426 Added 917.37%	533,905 $8.04 Million
Q2 2023 Aug 03, 2023	BUY	$21.6 - $30.69 $235,677 - $334,858	10,911 Added 26.25%	52,479 $1.13 Million
Q1 2023 May 04, 2023	BUY	$23.07 - $32.77 $102,130 - $145,072	4,427 Added 11.92%	41,568 $1.17 Million
Q4 2022 Feb 13, 2023	BUY	$25.29 - $35.48 $357,423 - $501,438	14,133 Added 61.43%	37,141 $941,000
Q3 2022 Nov 03, 2022	SELL	$24.0 - $33.42 $151,824 - $211,414	-6,326 Reduced 21.57%	23,008 $663,000
Q2 2022 Aug 12, 2022	BUY	$24.78 - $33.36 $726,896 - $978,582	29,334 New	29,334 $742,000

Others Institutions Holding EMBC

# of Institutions

411

Shares Held

57.3M

Call Options Held

54.8K

Put Options Held

32.3K

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $797M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account